Application
Western blot analysis of extracts of various tissues, using FGF9 antibody.
WB
(a,b) The FGF9 mRNA and the protein expression level were measured by RT-PCR and western blot analysis in ischemia–hypoxia cardiomyocytes and control groups. (c,d) The results of FGF9 mRNA and protein expression level in AMI rats and healthy controls on RT-PCR and western blot analysis analysis.
WB
(f,g) The results of FGF9 mRNA and protein expression level in cardiomyocytes after overexpression of lncRNA FAF.
WB
(a,b) The FGF9 mRNA and the protein expression level were determined in cardiomyocytes following the treatment with siRNA adenovirus.